Genesis begins clinical trial for potential COVID-19 treatment
April 24, 2020
Two patients at Genesis Health System are undergoing convalescent plasma therapy, as part of a Mayo Clinic clinical trial. READ MORE
Two patients at Genesis Health System are undergoing convalescent plasma therapy, as part of a Mayo Clinic clinical trial. READ MORE
NASHVILLE, Tenn. (WKRN) — Research to help patients recover from COVID-19 heads into its second phase tomorrow at Vanderbilt University Medical Center. The study is called “Pass It On” which stands for, PASSive Immunity Trial Of Nashville. READ MORE
Premier Health First in the Nation to Treat COVID-19 Positive Patient Using Mayo Clinic Protocols DAYTON, Ohio (April 9, 2020) – Local residents who have recovered from COVID-19 now have a unique opportunity to contribute to efforts to defeat the virus through the Community Blood Center’s new COVID-19 Convalescent Plasma
America’s Blood Centers (ABC) has distributed a national news release regarding the role that community blood centers are playing in the collection of CCP as part of the nation’s response efforts to COVID-19. Additionally, ABC, AABB, and the American Red Cross have developed a joint statement on CCP to align
The AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism issued the following statement regarding blood donation during the COVID-19 pandemic. READ MORE
March 16, 2020 Contact: Roger Ruiz C: 210-296-9026 roger.ruiz@biobridgeglobal.org Alamodome to host three-day blood drive to maintain local blood supply, avoid public health emergency Venue allows for proper social distancing; all donors will be required to make appointments to manage flow and avoid crowding SAN ANTONIO, Texas – The South
“We Need People to Start Turning Out in Force to Give Blood” FDA Urging People to Donate Blood as Coronavirus Fears Intensify (Washington, DC – March 12, 2020) – “We need people to start turning out in force to give blood.” That urgent call-to-action coming from Peter Marks, M.D., Ph.D.,
For immediate release March 9, 2020 Contact: Ashley Frolick GenCure Communications Specialist 210-487-1985 Ashley.frolick@biobridgeglobal.org MTEC selects BioBridge Global as recipient of Prototype of the Year Award Recognition due to advancing large-scale manufacturing capabilities for clinical-grade adult stem cells for research and new therapies SAN ANTONIO,
FDA grants South Texas Blood & Tissue Center first license for new process that triples shelf life of critically needed platelets Breakthrough expected to increase availability of platelets for treating cancer patients and active bleeding cases Click to Read More
NEWS RELEASE Heather Browne ∙ Marketing & Media Manager 405-419-1330 ∙ Cell 405-623-9321 Email ∙ heather.browne@obi.org Oklahoma Blood Institute Names Kim van Antwerpen Chief Operating Officer October 16, 2019 – Oklahoma Blood Institute is proud to announce Kim van Antwerpen as its Chief Operating Officer, a new
phone 401-381-0600
fax 401-381-0016
address 1300 Division Road, Suite 102 West Warwick, Rhode Island 02893
email info@bca.coop
